TrialDiabetes care2011

The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study).

Guillaume Charpentier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.